info@synchemia.com | sales@synchemia.com 
9766925136 
Lacosamide
Lacosamide | CAS NO: 175481-36-4, Epilepsy: Lacosamide is used to treat partial-onset seizures in patients with epilepsy, both as monotherapy (when used alone) and as adjunctive therapy (when used with other medications). Neuropathic Pain: It is sometimes used off-label to help manage neuropathic pain, a type of chronic pain that occurs due to nerve damage or dysfunction.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Lacosamide impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities The exact way lacosamide works in these conditions is not fully understood, but it is believed to help by stabilizing electrical activity in the brain and reducing abnormal neuronal firing, which is important in preventing seizures and alleviating nerve pain. Buy Reliable and High-Purity Lacosamide Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-L12327 |
| CAS No | 1379592-19-4 |
| Mol.F. | C11H16N2O2 : C2H2O4 |
| Mol.Wt. | 208.3 : 90.0 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12328 |
| CAS No | 1822463-67-1 |
| Mol.F. | C14H18N2O4 |
| Mol.Wt. | 278.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12329 |
| CAS No | 1318777-56-8 |
| Mol.F. | C14H20N2O3 |
| Mol.Wt. | 264.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12330 |
| CAS No | 2764892-65-9 |
| Mol.F. | C14H20N2O3 |
| Mol.Wt. | 264.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12331 |
| CAS No | 140-11-4 |
| Mol.F. | C9H10O2 |
| Mol.Wt. | 150.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12332 |
| CAS No | 98632-99-6 |
| Mol.F. | C6H11NO4 |
| Mol.Wt. | 161.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12333 |
| CAS No | 1253790-25-8 |
| Mol.F. | C16H24N2O4 |
| Mol.Wt. | 308.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12334 |
| CAS No | NA |
| Mol.F. | C13H16N2O4 |
| Mol.Wt. | 264.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12335 |
| CAS No | 141108-78-3 |
| Mol.F. | C15H22N2O4 |
| Mol.Wt. | 294.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12336 |
| CAS No | 474534-78-6 |
| Mol.F. | C11H16N2O2 |
| Mol.Wt. | 208.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12337 |
| CAS No | 1253790-58-7 |
| Mol.F. | C15H22N2O4 |
| Mol.Wt. | 294.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12338 |
| CAS No | 69805-82-9 |
| Mol.F. | C12H17NO2 |
| Mol.Wt. | 207.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12339 |
| CAS No | 934169-87-6 |
| Mol.F. | C15H22N2O4 |
| Mol.Wt. | 294.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12340 |
| CAS No | 1352305-14-6 |
| Mol.F. | C16H24N2O4 |
| Mol.Wt. | 308.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-L12341 |
| CAS No | 2041100-16-5 |
| Mol.F. | C11H16N2O2 : HCl |
| Mol.Wt. | 208.3 : 36.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
